Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 6 studies | 22% ± 4% | |
| ciliated cell | 5 studies | 21% ± 4% | |
| endothelial cell | 5 studies | 30% ± 11% | |
| epithelial cell | 5 studies | 28% ± 6% | |
| macrophage | 5 studies | 24% ± 4% | |
| myeloid cell | 4 studies | 18% ± 2% | |
| classical monocyte | 3 studies | 26% ± 6% | |
| microglial cell | 3 studies | 26% ± 1% | |
| GABAergic neuron | 3 studies | 33% ± 12% | |
| glutamatergic neuron | 3 studies | 42% ± 14% | |
| dendritic cell | 3 studies | 30% ± 14% | |
| basal cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6633.37 | 1445 / 1445 | 100% | 65.80 | 183 / 183 |
| stomach | 100% | 5510.18 | 359 / 359 | 100% | 49.95 | 286 / 286 |
| lung | 100% | 7272.09 | 578 / 578 | 100% | 46.92 | 1154 / 1155 |
| intestine | 100% | 7188.14 | 966 / 966 | 100% | 46.54 | 526 / 527 |
| bladder | 100% | 6424.76 | 21 / 21 | 100% | 41.59 | 503 / 504 |
| breast | 100% | 6568.94 | 459 / 459 | 100% | 70.77 | 1115 / 1118 |
| thymus | 100% | 7184.65 | 653 / 653 | 100% | 44.20 | 603 / 605 |
| prostate | 100% | 5699.30 | 245 / 245 | 100% | 47.33 | 500 / 502 |
| skin | 100% | 7889.20 | 1809 / 1809 | 100% | 60.04 | 470 / 472 |
| uterus | 100% | 6751.23 | 170 / 170 | 100% | 38.35 | 457 / 459 |
| brain | 99% | 5431.61 | 2628 / 2642 | 100% | 45.45 | 705 / 705 |
| kidney | 100% | 6868.07 | 89 / 89 | 99% | 41.48 | 895 / 901 |
| pancreas | 99% | 4112.48 | 324 / 328 | 100% | 36.35 | 178 / 178 |
| ovary | 100% | 6855.46 | 180 / 180 | 97% | 34.60 | 418 / 430 |
| adrenal gland | 100% | 8660.81 | 258 / 258 | 93% | 32.03 | 215 / 230 |
| liver | 92% | 3005.85 | 209 / 226 | 89% | 18.48 | 362 / 406 |
| adipose | 100% | 6770.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 6345.83 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 52.80 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 41.44 | 29 / 29 |
| muscle | 100% | 7281.74 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 7257.05 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 44.75 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 12.46 | 1 / 1 |
| heart | 98% | 4436.79 | 841 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 92% | 4541.21 | 857 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0031966 | Cellular component | mitochondrial membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0140268 | Cellular component | endoplasmic reticulum-plasma membrane contact site |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0035091 | Molecular function | phosphatidylinositol binding |
| Gene name | BLTP2 |
| Protein name | Bridge-like lipid transfer protein family member 2 Bridge-like lipid transfer protein family member 2 (KIAA0100, isoform CRA_a) Bridge-like lipid transfer protein family member 2 (Antigen MLAA-22) (Breast cancer-overexpressed gene 1 protein) (Protein hobbit homolog) FMP27/BLTP2 N-terminal domain-containing protein KIAA0100 protein |
| Synonyms | KIAA0100 BCOX1 hCG_31795 |
| Description | FUNCTION: Tube-forming lipid transport protein which binds to phosphatidylinositols and affects phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P2) distribution. . |
| Accessions | Q14667 ENST00000528896.7 [Q14667-1] ENST00000583403.5 ENST00000577261.1 K7EQR3 G1UI35 K7EQ86 ENST00000581267.1 Q08E86 ENST00000389003.7 J3QLM5 K7EMT1 |